A recent survey conducted by the HIV Medicine Association identified barriers to implementation of long-acting injectables ...
Research by UMass Chan Medical School scientists Sharon Cantor, Ph.D., and Jenna M. Whalen, Ph.D., poses a new explanation ...
In parts of the world where traveling to a clinic for routine blood tests is a financial and logistical challenge, HIV ...
Warfarin was associated with more risk than apixaban (Eliquis; 55.38 vs 21.42 per 1,000 person-years, HR 2.60, 95% CI ...
Bits of viral genes incorporated into human DNA have been linked to cancer, ALS and schizophrenia. But many of these genes ...
To tackle the ongoing high burden of hepatitis C virus (HCV) infections among people who inject drugs (PWID), WHO has set a specific incidence target among PWID of no more than two new infections per ...
New research has found little natural resistance to a new HIV therapy, adding to evidence that it may be a powerful tool in ...
A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...
An HIV drug was named “2024 Breakthrough of the Year” by Science Magazine. Biochemistry research from the University of Utah ...
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, is pleased to announce it has successfully completed ...
Twenty million people around the world died before the program was founded. Now millions of people take drugs known as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback